Global siRNA Drugs Market Research Report 2026(Status and Outlook)
Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA at first non-coding RNA molecules, typically 20?24 (normally 21) base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. siRNA plays a crucial role in gene silencing and regulation of gene expression. siRNA-based therapeutics have gained significant attention in recent years due to their potential to target specific genes involved in diseases such as cancer, genetic disorders, viral infections, and neurodegenerative diseases. The scope of siRNA drug products encompasses various aspects, including their design, development, testing, and regulatory approval.Core manufacturers of siRNA Drugs include Alnylam, Novartis, Novo Nordisk, Genzyme and Arrowhead. USA is the largest consumption region, accounting for approximately 57% of the global market, followed by Europe. In terms of product type, subcutaneous injection are the largest market segment, with a share of more than 77%. In terms of product application, the largest application market is nervous system therapy, with a share of approximately 52%.In-depth analysis of siRNA drug market driving factorsI. Technological breakthroughs: the leap from laboratory to clinicDelivery system innovationLipid nanoparticle (LNP) technology optimization: Early siRNA drugs were limited to the field of rare diseases due to low delivery efficiency and insufficient targeting. In recent years, through technological breakthroughs such as ionized lipid component improvement and PEG modification, LNP can achieve liver-targeted delivery (such as Alnylam's Onpattro) or cross the blood-brain barrier (such as Denali's RVT-1201), significantly broadening the scope of indications.Popularization of GalNAc coupling technology: This technology achieves efficient liver-targeted delivery by binding to asialoglycoprotein receptors, reducing the frequency of administration (such as Novartis' Leqvio subcutaneous injection once every six months), and promoting siRNA to penetrate into chronic diseases such as cardiovascular and metabolic diseases.Mature chemical modification technologyImproved stability: Through 2'-O-methyl modification, thiophosphate backbone and other technologies, the half-life of siRNA is extended to several weeks, reducing the risk of immunogenicity.Reduced off-target effects: AI-assisted sequence design (such as Sirnaomics' AI algorithm) combined with bioinformatics screening improves siRNA specificity and significantly improves clinical safety.2. Market demand: The outbreak of unmet clinical needsIndications expand from rare diseases to common diseasesBreakthrough in chronic diseases: Among the approximately 1 billion cardiovascular disease patients worldwide, the market potential for hypercholesterolemia is huge.New paradigm for tumor treatment: siRNA combined with PD-1 inhibitors (such as Arrowhead's ARO-HIF2) shows synergistic effects in the treatment of renal cancer, pushing tumor immunotherapy into the era of gene regulation.The rise of personalized medicine: siRNA therapy based on genotyping (such as Alzheimer's disease drugs for patients with APOE4 mutations) meets the needs of precision treatment and increases patients' willingness to pay.3. Policy support: Improvement of the global regulatory frameworkChina's policy dividends"The 14th Five-Year Plan for the Development of the Pharmaceutical Industry": Clearly support the development of new delivery systems and nucleic acid drugs, and provide tax incentives and research and development subsidies.Priority review channel: CDE implements fast approval for innovative siRNA drugs, such as Sirnaomics' STP705 (treatment of squamous cell skin cancer) included in the breakthrough therapy.International regulatory coordinationFDA accelerated approval: Onpattro (2018) was approved as the first siRNA drug, turning on the regulatory green light.EMA adaptive path: Allows conditional approval based on alternative endpoints (such as biomarker changes) to shorten the R&D cycle.IV. Capital influx: catalytic effect of industrial ecologyIncreased investment and financing activityGlobal capital layout: 33 financings in the field of small nucleic acid drugs in 2022, with an amount of nearly US$6 billion (such as Sirnaomics IPO raising US$150 million).MNC giants enter the market: Roche acquires Dicerna for US$2.8 billion, and Novartis and Alnylam reach a US$3.5 billion cooperation to accelerate pipeline development.CDMO service ecosystem maturesRiboBio, WuXi AppTec: Provide "one-stop" services from sequence design to cGMP production, reducing R&D costs by more than 50%.Breakthrough in large-scale production: Through continuous flow synthesis technology, the annual production capacity of siRNA has been increased from grams to kilograms, and the cost per dose has been reduced to less than $100.V. Competitive landscape: From technical barriers to ecological barriersStrengthening of patent layoutCore patents for delivery systems: Alnylam owns key technology patent clusters such as LNP and GalNAc, forming a technological monopoly.Chemical modification patent network: Ionis' 2'-MOE modification and Sirnaomics' GalNAc-siRNA coupling technology build a patent moat.Cross-border cooperation is acceleratingPharmaceutical company-biotechnology company alliance: For example, AstraZeneca and Silence Therapeutics cooperate to develop cardiovascular siRNA drugs, sharing R&D risks and benefits.Collaborative innovation between industry, academia and research: Harvard University and Moderna cooperate to develop RNA editing technology to promote the transformation of basic research to clinical practice.VI. Challenges and coping strategiesBreakthrough in technical bottlenecksImproved tissue penetration: Through cell penetrating peptide (CPP) modification or exosome delivery, the problem of siRNA delivery in organs such as the lungs and brain is solved.Long-term safety assessment: Establish real-time quantitative PCR to monitor off-target effects, and optimize sequence design in combination with single-cell sequencing technology.Balance between cost and accessibilityTiered pricing strategy: Adopt the "patent pool" model (such as MPP) in low-income countries to improve drug accessibility.In the future, siRNA drugs are expected to become the third largest drug type after small molecules and antibodies, reshaping the biopharmaceutical industry landscape. Companies need to focus on core technology breakthroughs, differentiated indication layout and global cooperation to seize market opportunities.
The global siRNA Drugs market size was estimated at USD 2443.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 28.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global siRNA Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global siRNA Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the siRNA Drugs market.
Global siRNA Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Alnylam
Novartis
Novo Nordisk
Genzyme
Arrowhead
Silence
Sylentis
Avidity Biosciences
Sirnaomics
Market Segmentation (by Type)
Intravenous Injection
Subcutaneous Injection
Market Segmentation (by Application)
Nervous System Therapy
Endocrine and Metabolic Therapy
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the siRNA Drugs Market
Overview of the regional outlook of the siRNA Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the siRNA Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of siRNA Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global siRNA Drugs market size was estimated at USD 2443.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 28.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global siRNA Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global siRNA Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the siRNA Drugs market.
Global siRNA Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Alnylam
Novartis
Novo Nordisk
Genzyme
Arrowhead
Silence
Sylentis
Avidity Biosciences
Sirnaomics
Market Segmentation (by Type)
Intravenous Injection
Subcutaneous Injection
Market Segmentation (by Application)
Nervous System Therapy
Endocrine and Metabolic Therapy
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the siRNA Drugs Market
Overview of the regional outlook of the siRNA Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the siRNA Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of siRNA Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of siRNA Drugs
1.2 Key Market Segments
1.2.1 siRNA Drugs Segment by Type
1.2.2 siRNA Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SIRNA DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global siRNA Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global siRNA Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SIRNA DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global siRNA Drugs Product Life Cycle
3.3 Global siRNA Drugs Sales by Manufacturers (2020-2025)
3.4 Global siRNA Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 siRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global siRNA Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 siRNA Drugs Market Competitive Situation and Trends
3.8.1 siRNA Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest siRNA Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SIRNA DRUGS INDUSTRY CHAIN ANALYSIS
4.1 siRNA Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SIRNA DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global siRNA Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to siRNA Drugs Market
5.7 ESG Ratings of Leading Companies
6 SIRNA DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global siRNA Drugs Sales Market Share by Type (2020-2025)
6.3 Global siRNA Drugs Market Size by Type (2020-2025)
6.4 Global siRNA Drugs Price by Type (2020-2025)
7 SIRNA DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global siRNA Drugs Market Sales by Application (2020-2025)
7.3 Global siRNA Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global siRNA Drugs Sales Growth Rate by Application (2020-2025)
8 SIRNA DRUGS MARKET SALES BY REGION
8.1 Global siRNA Drugs Sales by Region
8.1.1 Global siRNA Drugs Sales by Region
8.1.2 Global siRNA Drugs Sales Market Share by Region
8.2 Global siRNA Drugs Market Size by Region
8.2.1 Global siRNA Drugs Market Size by Region
8.2.2 Global siRNA Drugs Market Size by Region
8.3 North America
8.3.1 North America siRNA Drugs Sales by Country
8.3.2 North America siRNA Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe siRNA Drugs Sales by Country
8.4.2 Europe siRNA Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific siRNA Drugs Sales by Region
8.5.2 Asia Pacific siRNA Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America siRNA Drugs Sales by Country
8.6.2 South America siRNA Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa siRNA Drugs Sales by Region
8.7.2 Middle East and Africa siRNA Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SIRNA DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of siRNA Drugs by Region(2020-2025)
9.2 Global siRNA Drugs Revenue Market Share by Region (2020-2025)
9.3 Global siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America siRNA Drugs Production
9.4.1 North America siRNA Drugs Production Growth Rate (2020-2025)
9.4.2 North America siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe siRNA Drugs Production
9.5.1 Europe siRNA Drugs Production Growth Rate (2020-2025)
9.5.2 Europe siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan siRNA Drugs Production (2020-2025)
9.6.1 Japan siRNA Drugs Production Growth Rate (2020-2025)
9.6.2 Japan siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China siRNA Drugs Production (2020-2025)
9.7.1 China siRNA Drugs Production Growth Rate (2020-2025)
9.7.2 China siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Alnylam
10.1.1 Alnylam Basic Information
10.1.2 Alnylam siRNA Drugs Product Overview
10.1.3 Alnylam siRNA Drugs Product Market Performance
10.1.4 Alnylam Business Overview
10.1.5 Alnylam SWOT Analysis
10.1.6 Alnylam Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis siRNA Drugs Product Overview
10.2.3 Novartis siRNA Drugs Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Novo Nordisk
10.3.1 Novo Nordisk Basic Information
10.3.2 Novo Nordisk siRNA Drugs Product Overview
10.3.3 Novo Nordisk siRNA Drugs Product Market Performance
10.3.4 Novo Nordisk Business Overview
10.3.5 Novo Nordisk SWOT Analysis
10.3.6 Novo Nordisk Recent Developments
10.4 Genzyme
10.4.1 Genzyme Basic Information
10.4.2 Genzyme siRNA Drugs Product Overview
10.4.3 Genzyme siRNA Drugs Product Market Performance
10.4.4 Genzyme Business Overview
10.4.5 Genzyme Recent Developments
10.5 Arrowhead
10.5.1 Arrowhead Basic Information
10.5.2 Arrowhead siRNA Drugs Product Overview
10.5.3 Arrowhead siRNA Drugs Product Market Performance
10.5.4 Arrowhead Business Overview
10.5.5 Arrowhead Recent Developments
10.6 Silence
10.6.1 Silence Basic Information
10.6.2 Silence siRNA Drugs Product Overview
10.6.3 Silence siRNA Drugs Product Market Performance
10.6.4 Silence Business Overview
10.6.5 Silence Recent Developments
10.7 Sylentis
10.7.1 Sylentis Basic Information
10.7.2 Sylentis siRNA Drugs Product Overview
10.7.3 Sylentis siRNA Drugs Product Market Performance
10.7.4 Sylentis Business Overview
10.7.5 Sylentis Recent Developments
10.8 Avidity Biosciences
10.8.1 Avidity Biosciences Basic Information
10.8.2 Avidity Biosciences siRNA Drugs Product Overview
10.8.3 Avidity Biosciences siRNA Drugs Product Market Performance
10.8.4 Avidity Biosciences Business Overview
10.8.5 Avidity Biosciences Recent Developments
10.9 Sirnaomics
10.9.1 Sirnaomics Basic Information
10.9.2 Sirnaomics siRNA Drugs Product Overview
10.9.3 Sirnaomics siRNA Drugs Product Market Performance
10.9.4 Sirnaomics Business Overview
10.9.5 Sirnaomics Recent Developments
11 SIRNA DRUGS MARKET FORECAST BY REGION
11.1 Global siRNA Drugs Market Size Forecast
11.2 Global siRNA Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe siRNA Drugs Market Size Forecast by Country
11.2.3 Asia Pacific siRNA Drugs Market Size Forecast by Region
11.2.4 South America siRNA Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of siRNA Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global siRNA Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of siRNA Drugs by Type (2026-2035)
12.1.2 Global siRNA Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of siRNA Drugs by Type (2026-2035)
12.2 Global siRNA Drugs Market Forecast by Application (2026-2035)
12.2.1 Global siRNA Drugs Sales (K Units) Forecast by Application
12.2.2 Global siRNA Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of siRNA Drugs
1.2 Key Market Segments
1.2.1 siRNA Drugs Segment by Type
1.2.2 siRNA Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SIRNA DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global siRNA Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global siRNA Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SIRNA DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global siRNA Drugs Product Life Cycle
3.3 Global siRNA Drugs Sales by Manufacturers (2020-2025)
3.4 Global siRNA Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 siRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global siRNA Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 siRNA Drugs Market Competitive Situation and Trends
3.8.1 siRNA Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest siRNA Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SIRNA DRUGS INDUSTRY CHAIN ANALYSIS
4.1 siRNA Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SIRNA DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global siRNA Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to siRNA Drugs Market
5.7 ESG Ratings of Leading Companies
6 SIRNA DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global siRNA Drugs Sales Market Share by Type (2020-2025)
6.3 Global siRNA Drugs Market Size by Type (2020-2025)
6.4 Global siRNA Drugs Price by Type (2020-2025)
7 SIRNA DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global siRNA Drugs Market Sales by Application (2020-2025)
7.3 Global siRNA Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global siRNA Drugs Sales Growth Rate by Application (2020-2025)
8 SIRNA DRUGS MARKET SALES BY REGION
8.1 Global siRNA Drugs Sales by Region
8.1.1 Global siRNA Drugs Sales by Region
8.1.2 Global siRNA Drugs Sales Market Share by Region
8.2 Global siRNA Drugs Market Size by Region
8.2.1 Global siRNA Drugs Market Size by Region
8.2.2 Global siRNA Drugs Market Size by Region
8.3 North America
8.3.1 North America siRNA Drugs Sales by Country
8.3.2 North America siRNA Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe siRNA Drugs Sales by Country
8.4.2 Europe siRNA Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific siRNA Drugs Sales by Region
8.5.2 Asia Pacific siRNA Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America siRNA Drugs Sales by Country
8.6.2 South America siRNA Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa siRNA Drugs Sales by Region
8.7.2 Middle East and Africa siRNA Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SIRNA DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of siRNA Drugs by Region(2020-2025)
9.2 Global siRNA Drugs Revenue Market Share by Region (2020-2025)
9.3 Global siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America siRNA Drugs Production
9.4.1 North America siRNA Drugs Production Growth Rate (2020-2025)
9.4.2 North America siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe siRNA Drugs Production
9.5.1 Europe siRNA Drugs Production Growth Rate (2020-2025)
9.5.2 Europe siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan siRNA Drugs Production (2020-2025)
9.6.1 Japan siRNA Drugs Production Growth Rate (2020-2025)
9.6.2 Japan siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China siRNA Drugs Production (2020-2025)
9.7.1 China siRNA Drugs Production Growth Rate (2020-2025)
9.7.2 China siRNA Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Alnylam
10.1.1 Alnylam Basic Information
10.1.2 Alnylam siRNA Drugs Product Overview
10.1.3 Alnylam siRNA Drugs Product Market Performance
10.1.4 Alnylam Business Overview
10.1.5 Alnylam SWOT Analysis
10.1.6 Alnylam Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis siRNA Drugs Product Overview
10.2.3 Novartis siRNA Drugs Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Novo Nordisk
10.3.1 Novo Nordisk Basic Information
10.3.2 Novo Nordisk siRNA Drugs Product Overview
10.3.3 Novo Nordisk siRNA Drugs Product Market Performance
10.3.4 Novo Nordisk Business Overview
10.3.5 Novo Nordisk SWOT Analysis
10.3.6 Novo Nordisk Recent Developments
10.4 Genzyme
10.4.1 Genzyme Basic Information
10.4.2 Genzyme siRNA Drugs Product Overview
10.4.3 Genzyme siRNA Drugs Product Market Performance
10.4.4 Genzyme Business Overview
10.4.5 Genzyme Recent Developments
10.5 Arrowhead
10.5.1 Arrowhead Basic Information
10.5.2 Arrowhead siRNA Drugs Product Overview
10.5.3 Arrowhead siRNA Drugs Product Market Performance
10.5.4 Arrowhead Business Overview
10.5.5 Arrowhead Recent Developments
10.6 Silence
10.6.1 Silence Basic Information
10.6.2 Silence siRNA Drugs Product Overview
10.6.3 Silence siRNA Drugs Product Market Performance
10.6.4 Silence Business Overview
10.6.5 Silence Recent Developments
10.7 Sylentis
10.7.1 Sylentis Basic Information
10.7.2 Sylentis siRNA Drugs Product Overview
10.7.3 Sylentis siRNA Drugs Product Market Performance
10.7.4 Sylentis Business Overview
10.7.5 Sylentis Recent Developments
10.8 Avidity Biosciences
10.8.1 Avidity Biosciences Basic Information
10.8.2 Avidity Biosciences siRNA Drugs Product Overview
10.8.3 Avidity Biosciences siRNA Drugs Product Market Performance
10.8.4 Avidity Biosciences Business Overview
10.8.5 Avidity Biosciences Recent Developments
10.9 Sirnaomics
10.9.1 Sirnaomics Basic Information
10.9.2 Sirnaomics siRNA Drugs Product Overview
10.9.3 Sirnaomics siRNA Drugs Product Market Performance
10.9.4 Sirnaomics Business Overview
10.9.5 Sirnaomics Recent Developments
11 SIRNA DRUGS MARKET FORECAST BY REGION
11.1 Global siRNA Drugs Market Size Forecast
11.2 Global siRNA Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe siRNA Drugs Market Size Forecast by Country
11.2.3 Asia Pacific siRNA Drugs Market Size Forecast by Region
11.2.4 South America siRNA Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of siRNA Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global siRNA Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of siRNA Drugs by Type (2026-2035)
12.1.2 Global siRNA Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of siRNA Drugs by Type (2026-2035)
12.2 Global siRNA Drugs Market Forecast by Application (2026-2035)
12.2.1 Global siRNA Drugs Sales (K Units) Forecast by Application
12.2.2 Global siRNA Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global siRNA Drugs Market Size by Type (M USD)
Table 4. Global siRNA Drugs Market Size by Application
Table 5. siRNA Drugs Market Size Comparison by Region (M USD)
Table 6. Global siRNA Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global siRNA Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global siRNA Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global siRNA Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drugs as of 2025)
Table 11. Global Market siRNA Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global siRNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. siRNA Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global siRNA Drugs Sales by Type (K Units)
Table 27. Global siRNA Drugs Market Size by Type (M USD)
Table 28. Global siRNA Drugs Sales (K Units) by Type (2020-2025)
Table 29. Global siRNA Drugs Sales Market Share by Type (2020-2025)
Table 30. Global siRNA Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global siRNA Drugs Market Share by Type (2020-2025)
Table 32. Global siRNA Drugs Price (USD/Unit) by Type (2020-2025)
Table 33. Global siRNA Drugs Sales (K Units) by Application
Table 34. Global siRNA Drugs Market Size by Application
Table 35. Global siRNA Drugs Sales by Application (2020-2025) & (K Units)
Table 36. Global siRNA Drugs Sales Market Share by Application (2020-2025)
Table 37. Global siRNA Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global siRNA Drugs Market Share by Application (2020-2025)
Table 39. Global siRNA Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global siRNA Drugs Sales by Region (2020-2025) & (K Units)
Table 41. Global siRNA Drugs Sales Market Share by Region (2020-2025)
Table 42. Global siRNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global siRNA Drugs Market Size by Region (2020-2025)
Table 44. North America siRNA Drugs Sales by Country (2020-2025) & (K Units)
Table 45. North America siRNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe siRNA Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Europe siRNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific siRNA Drugs Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific siRNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America siRNA Drugs Sales by Country (2020-2025) & (K Units)
Table 51. South America siRNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa siRNA Drugs Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa siRNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global siRNA Drugs Production (K Units) by Region(2020-2025)
Table 55. Global siRNA Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global siRNA Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Alnylam Basic Information
Table 63. Alnylam siRNA Drugs Product Overview
Table 64. Alnylam siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Alnylam Business Overview
Table 66. Alnylam SWOT Analysis
Table 67. Alnylam Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis siRNA Drugs Product Overview
Table 70. Novartis siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Novo Nordisk Basic Information
Table 75. Novo Nordisk siRNA Drugs Product Overview
Table 76. Novo Nordisk siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk SWOT Analysis
Table 79. Novo Nordisk Recent Developments
Table 80. Genzyme Basic Information
Table 81. Genzyme siRNA Drugs Product Overview
Table 82. Genzyme siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Genzyme Business Overview
Table 84. Genzyme Recent Developments
Table 85. Arrowhead Basic Information
Table 86. Arrowhead siRNA Drugs Product Overview
Table 87. Arrowhead siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Arrowhead Business Overview
Table 89. Arrowhead Recent Developments
Table 90. Silence Basic Information
Table 91. Silence siRNA Drugs Product Overview
Table 92. Silence siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Silence Business Overview
Table 94. Silence Recent Developments
Table 95. Sylentis Basic Information
Table 96. Sylentis siRNA Drugs Product Overview
Table 97. Sylentis siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sylentis Business Overview
Table 99. Sylentis Recent Developments
Table 100. Avidity Biosciences Basic Information
Table 101. Avidity Biosciences siRNA Drugs Product Overview
Table 102. Avidity Biosciences siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Avidity Biosciences Business Overview
Table 104. Avidity Biosciences Recent Developments
Table 105. Sirnaomics Basic Information
Table 106. Sirnaomics siRNA Drugs Product Overview
Table 107. Sirnaomics siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sirnaomics Business Overview
Table 109. Sirnaomics Recent Developments
Table 110. Global siRNA Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 111. Global siRNA Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America siRNA Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 113. North America siRNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe siRNA Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 115. Europe siRNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific siRNA Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 117. Asia Pacific siRNA Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America siRNA Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 119. South America siRNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa siRNA Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa siRNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global siRNA Drugs Sales Forecast by Type (2026-2035) & (K Units)
Table 123. Global siRNA Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global siRNA Drugs Price Forecast by Type (2026-2035) & (USD/Unit)
Table 125. Global siRNA Drugs Sales (K Units) Forecast by Application (2026-2035)
Table 126. Global siRNA Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global siRNA Drugs Market Size by Type (M USD)
Table 4. Global siRNA Drugs Market Size by Application
Table 5. siRNA Drugs Market Size Comparison by Region (M USD)
Table 6. Global siRNA Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global siRNA Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global siRNA Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global siRNA Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drugs as of 2025)
Table 11. Global Market siRNA Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global siRNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. siRNA Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global siRNA Drugs Sales by Type (K Units)
Table 27. Global siRNA Drugs Market Size by Type (M USD)
Table 28. Global siRNA Drugs Sales (K Units) by Type (2020-2025)
Table 29. Global siRNA Drugs Sales Market Share by Type (2020-2025)
Table 30. Global siRNA Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global siRNA Drugs Market Share by Type (2020-2025)
Table 32. Global siRNA Drugs Price (USD/Unit) by Type (2020-2025)
Table 33. Global siRNA Drugs Sales (K Units) by Application
Table 34. Global siRNA Drugs Market Size by Application
Table 35. Global siRNA Drugs Sales by Application (2020-2025) & (K Units)
Table 36. Global siRNA Drugs Sales Market Share by Application (2020-2025)
Table 37. Global siRNA Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global siRNA Drugs Market Share by Application (2020-2025)
Table 39. Global siRNA Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global siRNA Drugs Sales by Region (2020-2025) & (K Units)
Table 41. Global siRNA Drugs Sales Market Share by Region (2020-2025)
Table 42. Global siRNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global siRNA Drugs Market Size by Region (2020-2025)
Table 44. North America siRNA Drugs Sales by Country (2020-2025) & (K Units)
Table 45. North America siRNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe siRNA Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Europe siRNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific siRNA Drugs Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific siRNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America siRNA Drugs Sales by Country (2020-2025) & (K Units)
Table 51. South America siRNA Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa siRNA Drugs Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa siRNA Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global siRNA Drugs Production (K Units) by Region(2020-2025)
Table 55. Global siRNA Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global siRNA Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China siRNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Alnylam Basic Information
Table 63. Alnylam siRNA Drugs Product Overview
Table 64. Alnylam siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Alnylam Business Overview
Table 66. Alnylam SWOT Analysis
Table 67. Alnylam Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis siRNA Drugs Product Overview
Table 70. Novartis siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Novo Nordisk Basic Information
Table 75. Novo Nordisk siRNA Drugs Product Overview
Table 76. Novo Nordisk siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk SWOT Analysis
Table 79. Novo Nordisk Recent Developments
Table 80. Genzyme Basic Information
Table 81. Genzyme siRNA Drugs Product Overview
Table 82. Genzyme siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Genzyme Business Overview
Table 84. Genzyme Recent Developments
Table 85. Arrowhead Basic Information
Table 86. Arrowhead siRNA Drugs Product Overview
Table 87. Arrowhead siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Arrowhead Business Overview
Table 89. Arrowhead Recent Developments
Table 90. Silence Basic Information
Table 91. Silence siRNA Drugs Product Overview
Table 92. Silence siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Silence Business Overview
Table 94. Silence Recent Developments
Table 95. Sylentis Basic Information
Table 96. Sylentis siRNA Drugs Product Overview
Table 97. Sylentis siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sylentis Business Overview
Table 99. Sylentis Recent Developments
Table 100. Avidity Biosciences Basic Information
Table 101. Avidity Biosciences siRNA Drugs Product Overview
Table 102. Avidity Biosciences siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Avidity Biosciences Business Overview
Table 104. Avidity Biosciences Recent Developments
Table 105. Sirnaomics Basic Information
Table 106. Sirnaomics siRNA Drugs Product Overview
Table 107. Sirnaomics siRNA Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sirnaomics Business Overview
Table 109. Sirnaomics Recent Developments
Table 110. Global siRNA Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 111. Global siRNA Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America siRNA Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 113. North America siRNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe siRNA Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 115. Europe siRNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific siRNA Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 117. Asia Pacific siRNA Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America siRNA Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 119. South America siRNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa siRNA Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa siRNA Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global siRNA Drugs Sales Forecast by Type (2026-2035) & (K Units)
Table 123. Global siRNA Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global siRNA Drugs Price Forecast by Type (2026-2035) & (USD/Unit)
Table 125. Global siRNA Drugs Sales (K Units) Forecast by Application (2026-2035)
Table 126. Global siRNA Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of siRNA Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global siRNA Drugs Market Size (M USD), 2025-2035
Figure 5. Global siRNA Drugs Market Size (M USD) (2020-2035)
Figure 6. Global siRNA Drugs Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. siRNA Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global siRNA Drugs Product Life Cycle
Figure 13. siRNA Drugs Sales Share by Manufacturers in 2025
Figure 14. Global siRNA Drugs Revenue Share by Manufacturers in 2025
Figure 15. siRNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market siRNA Drugs Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by siRNA Drugs Revenue in 2025
Figure 18. Industry Chain Map of siRNA Drugs
Figure 19. Global siRNA Drugs Market PEST Analysis
Figure 20. Global siRNA Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global siRNA Drugs Market Share by Type
Figure 27. Sales Market Share of siRNA Drugs by Type (2020-2025)
Figure 28. Sales Market Share of siRNA Drugs by Type in 2025
Figure 29. Market Share of siRNA Drugs by Type (2020-2025)
Figure 30. Market Share of siRNA Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global siRNA Drugs Market Share by Application
Figure 33. Global siRNA Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global siRNA Drugs Sales Market Share by Application in 2025
Figure 35. Global siRNA Drugs Market Share by Application (2020-2025)
Figure 36. Global siRNA Drugs Market Share by Application in 2025
Figure 37. Global siRNA Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global siRNA Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global siRNA Drugs Market Size by Region (2020-2025)
Figure 40. North America siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America siRNA Drugs Sales Market Share by Country in 2024
Figure 43. North America siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America siRNA Drugs Market Size by Country in 2024
Figure 45. U.S. siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada siRNA Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada siRNA Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico siRNA Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico siRNA Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe siRNA Drugs Sales Market Share by Country in 2024
Figure 53. Europe siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe siRNA Drugs Market Size by Country in 2024
Figure 55. Germany siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific siRNA Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific siRNA Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific siRNA Drugs Market Size by Region in 2024
Figure 68. China siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America siRNA Drugs Sales and Growth Rate (K Units)
Figure 79. South America siRNA Drugs Sales Market Share by Country in 2024
Figure 80. South America siRNA Drugs Market Size and Growth Rate (M USD)
Figure 81. South America siRNA Drugs Market Size by Country in 2024
Figure 82. Brazil siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa siRNA Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa siRNA Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa siRNA Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa siRNA Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global siRNA Drugs Production Market Share by Region (2020-2025)
Figure 103. North America siRNA Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe siRNA Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan siRNA Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China siRNA Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global siRNA Drugs Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global siRNA Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global siRNA Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global siRNA Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global siRNA Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global siRNA Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of siRNA Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global siRNA Drugs Market Size (M USD), 2025-2035
Figure 5. Global siRNA Drugs Market Size (M USD) (2020-2035)
Figure 6. Global siRNA Drugs Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. siRNA Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global siRNA Drugs Product Life Cycle
Figure 13. siRNA Drugs Sales Share by Manufacturers in 2025
Figure 14. Global siRNA Drugs Revenue Share by Manufacturers in 2025
Figure 15. siRNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market siRNA Drugs Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by siRNA Drugs Revenue in 2025
Figure 18. Industry Chain Map of siRNA Drugs
Figure 19. Global siRNA Drugs Market PEST Analysis
Figure 20. Global siRNA Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global siRNA Drugs Market Share by Type
Figure 27. Sales Market Share of siRNA Drugs by Type (2020-2025)
Figure 28. Sales Market Share of siRNA Drugs by Type in 2025
Figure 29. Market Share of siRNA Drugs by Type (2020-2025)
Figure 30. Market Share of siRNA Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global siRNA Drugs Market Share by Application
Figure 33. Global siRNA Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global siRNA Drugs Sales Market Share by Application in 2025
Figure 35. Global siRNA Drugs Market Share by Application (2020-2025)
Figure 36. Global siRNA Drugs Market Share by Application in 2025
Figure 37. Global siRNA Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global siRNA Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global siRNA Drugs Market Size by Region (2020-2025)
Figure 40. North America siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America siRNA Drugs Sales Market Share by Country in 2024
Figure 43. North America siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America siRNA Drugs Market Size by Country in 2024
Figure 45. U.S. siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada siRNA Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada siRNA Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico siRNA Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico siRNA Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe siRNA Drugs Sales Market Share by Country in 2024
Figure 53. Europe siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe siRNA Drugs Market Size by Country in 2024
Figure 55. Germany siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific siRNA Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific siRNA Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific siRNA Drugs Market Size by Region in 2024
Figure 68. China siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America siRNA Drugs Sales and Growth Rate (K Units)
Figure 79. South America siRNA Drugs Sales Market Share by Country in 2024
Figure 80. South America siRNA Drugs Market Size and Growth Rate (M USD)
Figure 81. South America siRNA Drugs Market Size by Country in 2024
Figure 82. Brazil siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa siRNA Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa siRNA Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa siRNA Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa siRNA Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa siRNA Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa siRNA Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global siRNA Drugs Production Market Share by Region (2020-2025)
Figure 103. North America siRNA Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe siRNA Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan siRNA Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China siRNA Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global siRNA Drugs Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global siRNA Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global siRNA Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global siRNA Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global siRNA Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global siRNA Drugs Market Share Forecast by Application (2026-2035)
